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1. Introduction
Mass gathering sporting and religious events pose important
public health challenges, including the transmission of infec-
tious diseases, exacerbation of non-communicable diseases, and
disorders related to climate change.1–5 Every year, the Kingdom
of Saudi Arabia (KSA) hosts the Hajj pilgrimage, which is the
largest mass gathering in the world held on a recurrent annual
basis.3 The Hajj occurs annually from the eighth to the 12th of
Dhul al-Hijah, the last (12th) month of the Islamic calendar,
and two to three million people perform the pilgrimage during
this period.3 A further seven million complete a ‘mini’ pilgrim-
age, known as Umrah, outside the Hajj period throughout
the year.
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S U M M A R Y
Mass gatherings at religious events can pose major public health challenges, particularly the
transmission of infectious diseases. Every year the Kingdom of Saudi Arabia (KSA) hosts the Hajj
pilgrimage, the largest gathering held on an annual basis where over 2 million people come to KSA from
over 180 countries. Living together in crowded conditions exposes the pilgrims and the local population
to a range infectious diseases. Respiratory and gastrointestinal tract bacterial and viral infections can
spread rapidly and affect attendees of mass gatherings. Lethal infectious disease outbreaks were
common during Hajj in the 19th and 20th centuries although they have now been controlled to a great
extent by the huge investments made by the KSA into public health prevention and surveillance
programs. The KSA provides regular updated Hajj travel advice and health regulations through
international public health agencies such as the WHO, Public Health England, the Centers for Disease
Control and Prevention, and Hajj travel agencies. During the Hajj, an additional 25 000 health workers are
deployed; there are eight hospitals in Makkah and Mina complete with state-of-the-art surgical wards
and intensive care units made speciﬁcally available for pilgrims. All medical facilities offer high quality of
care, and services are offered free to Hajj pilgrims to ensure the risks of ill health to all pilgrims and KSA
residents are minimal. A summary of the key health issues that arise in pilgrims from Europe during Hajj
and of the KSA Hajj guidelines, together with other factors that may play a role in reducing the risks to
pilgrims and to wider global health security, is provided herein.
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In light of the huge number of pilgrims from all around the world –
of which thousands come from low-income countries with minimal
access to healthcare – mixing closely for several days in a difﬁcult
terrain, it is remarkable that the majority of pilgrims complete the
Hajj without experiencing any major health issues. Infectious disease
outbreaks were common during Hajj in the 19th and 20th centuries
and have been controlled to a great extent, although proactive
surveillance of the transmission of potential epidemic threats at Hajj
is critical to preserving global health security.3,5 Crush injuries and
stampedes, which can pose major risks at mass gatherings, are
infrequent during the Hajj relative to its size and logistical
complexity. A summary of the key health issues that arise in pilgrims
from Europe during Hajj and of the KSA Hajj guidelines, together with
other factors that may play a role in reducing the risks to pilgrims and
to wider global health security, is provided herein.
2. Health risks during the Hajj
2.1. Communicable diseases
Respiratory and gastrointestinal tract bacterial and viral
infections spread rapidly and affect almost all pilgrims during
Hajj.6–13 Respiratory tract infections – whose spread through
coughing and sneezing is exacerbated by the crowded Hajj
conditions – include community-acquired pneumonia, inﬂuenza,
and tuberculosis (TB). While bacterial and viral pneumonia are
well-documented causes of hospital admission in pilgrims,13
quantifying the increase in risk of TB transmission is more
challenging owing to the longer time period between infection and
the development of symptoms. The elderly and those with
comorbid diseases such as diabetes are particularly vulnerable
to morbidity from respiratory illnesses.
2.2. Gastrointestinal disorders
Acute food poisoning is common during the Hajj and is caused
by toxins produced by Staphylococcus aureus and Bacillus cereus.
Gastroenteritis due to Salmonella spp and viruses such as rotavirus
and norovirus are common during Hajj.3,12 Factors responsible for
increasing the spread of gastrointestinal diseases during Hajj
include contamination of food through unhygienic preparation,
prolonged storage of food, drinking from contaminated water
sources, and a shortage of water for hand washing. The risks of
dehydration are heightened when Hajj occurs during summer
months, owing to the extremely hot climate in Saudi Arabia.14
Other infectious disease risks include meningococcal disease,
which caused outbreaks during Hajj in the early 2000s owing to
overcrowding and high carrier rates of Neisseria meningitidis among
pilgrims.3,15–17Mosquito species responsible for the transmission of
malaria and the arbovirus that causes dengue are present in the KSA,
although the country has been classiﬁed by the World Health
Organization (WHO) as a low, geographically restricted malaria
transmission area since 2008.3
2.3. Non-communicable diseases
Historically, infectious diseases were the largest cause of
morbidity and mortality during Hajj, but non-communicable
diseases are now a major burden.3 Many pilgrims both elderly and
young have existing non-communicable diseases such as diabetes,
hypertension, arthritis, epilepsy, liver and kidney disease, which
can be worsened by strenuous Hajj conditions or if regular
medications are neglected during the spiritual activities. In
addition to cardiovascular disease, heat exhaustion and heatstroke
are important causes of death; again health-related morbidity is
exacerbated when Hajj occurs during the summer months.
2.4. Fire and trauma
The risk of injury from ﬁres has been reduced since tents were
replaced with ﬁbreglass and cooking in tents was prohibited
following a ﬁre in 1997. However, risks from stampedes and crush
injuries remain due to the overcrowding. As the events of the
falling cranes and the stampede in the 2015 Hajj illustrate, trauma
can be a major cause of injury and death during Hajj. Furthermore,
many pilgrims who walk long distances as part of the rituals
invariably are injured by motor vehicles.
3. Factors reducing health risks (Table 1)
Table 1
3.1. Pre-Hajj preparations
The KSA Government employs a well-coordinated, inter-
sectoral approach to the planning, communication, public health,
and safety issues of the Hajj.3 Planning for Hajj starts soon after the
end of the current Hajj and the KSA Ministry of Hajj and Ministry of
Health liaise with the governments of all countries from which
pilgrims come to the KSA. Recommendations discussed are pre-
travel health regulations and advice about vaccinations, health
checks, and speciﬁc immunizations at the port of entry. Well before
each Hajj, the Saudi Ministry of Health generates the health
requirements for the issue of travel visas. It also provides health
education campaigns through the provision of reading materials
and through travel agents, pilgrim group leaders, websites, and the
media, both before and during the Hajj.
The KSA Government also provides regular updated Hajj travel
advice and health regulations through international public health
agencies such as the WHO, Public Health England, the Centers for
Disease Control and Prevention (CDC), and Hajj travel agencies.
For the 2015 Hajj, for example, alerts were raised for the prevailing
global threats from Middle East respiratory syndrome coronavirus
(MERS-CoV), inﬂuenza and other respiratory tract viruses,
multidrug-resistant TB, multi-antibiotic-resistant bacteria, and
Ebola.18–21,6,22,23
3.2. Measures taken during Hajj
During the Hajj, an additional 25 000 health workers are
deployed; there are eight hospitals in Makkah and Mina complete
with state-of-the-art surgical wards and intensive care units made
speciﬁcally available for pilgrims.3 All medical facilities offer high
quality of care, and services are offered free to Hajj pilgrims to
ensure the risks of ill health to all pilgrims and KSA residents are
minimal.
In terms of preventative measures, in addition to the vaccina-
tion requirements described below, measures are put in place to
ensure food safety and the Ministry of Health ensures strict
enforcement of the regulation that pilgrims are not allowed to
bring fresh food or agricultural products into the country. Other
coordinated activities include targeted insecticide spraying to
control mosquito populations, the distribution of health promotion
materials to pilgrims, and electronic surveillance of infectious
diseases.3
3.3. Hajj regulations for incoming pilgrims
The health requirements for pilgrimage to Mecca (Hajj and
Umrah) are published annually by the KSA Government. Informa-
tion for pilgrims is made available on the Saudi Arabia Ministry of
Health website.24–26
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Meningococcal vaccine is a prerequisite for all pilgrims; Hajj
visas cannot be issued without proof of meningococcal vaccina-
tion. All adults and children aged >2 years must have received a
single dose of quadrivalent A/C/Y/W-135 vaccine and must show
proof of vaccination on a valid International Certiﬁcate of
Vaccination or Prophylaxis. Children between 3 months and
2 years of age must show proof of vaccination with two doses of
meningococcal A monovalent vaccine with a 3-month interval
between the doses. Hajj pilgrims need to have had the
meningococcal vaccine 3 years and 10 days before arriving
in Saudi Arabia.
Other vaccination requirements for Hajj pilgrims entering
from speciﬁc countries include yellow fever and polio vaccines.
The yellow fever vaccine is mandatory for all travellers arriving
from countries listed by the WHO as being a yellow fever risk.
Polio vaccine is required for travellers arriving from countries that
have polio virus circulating, or from countries at high risk of re-
importation of polio virus, regardless of age and vaccination
status. Those who do not have evidence certiﬁcates are immu-
nized at the port of entry.3 The Saudi Ministry of Health
recommends seasonal inﬂuenza vaccine for those at increased
risk, such as the elderly and those with chronic comorbidities.24
However, there is conﬂicting evidence about the efﬁcacy of
inﬂuenza vaccine in protecting Hajj pilgrims.27,28 Pneumonia is
among the most common causes of hospital admission during
Hajj,14 and thus the prevention of pneumococcal infection is
crucial. Pneumococcal polysaccharide vaccine is recommended
for pilgrims aged 65 years and for younger pilgrims with
comorbidities.29 Finally, with regard to measles and rubella
vaccines, updating immunization against vaccine-preventable
diseases in all travellers is strongly recommended.
4. Lessons for and beyond mass gatherings
The prevention and management of threats to global health
security and protecting the health and lives of pilgrims requires
effective cooperation between numerous agencies within and
outside the KSA.30 The Hajj can therefore provide important
lessons for setting up and maintaining inter-sectoral collabora-
tions, for example between agencies responsible for health,
transport, border control, and environmental health. The value
of the Hajj experience to planners of mass gatherings in sharing
best practices is evident, but lessons can go beyond mass
gatherings to inform other areas of public health that require
inter-sectoral engagement, such as One Health and the control of
antimicrobial resistance. The Hajj also provides an opportunity for
research, not only into all aspects of mass gatherings, but also into
faith-based health promotion and electronic disease surveillance
capacity building.
Conﬂict of interest: All authors have an interest in infectious
diseases transmission at mass gatherings.
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